Abstract
BackgroundUntil recently, the development of clinical detectable arthritis was considered as the start of Rheumatoid Arthritis (RA). Several studies have revealed that anti-citrullinated peptide antibodies (ACPA) can be present and...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have